United States · Health Care · USD (Thousands) · Annual
Key financials
USD|Thousands
ROE
-0.78%
2025 (actual)
ROA
-0.67%
2025 (actual)
Gross Margin
32.33%
2025 (actual)
Net Margin
-1.12%
2025 (actual)
Total Assets
$13,653.05K
2025 (actual)
Net Income
-$100.46K
2025 (actual)
Valuation
$9,009.53K
2026 (forecast)
Stock Price
$0.39
Historical & projected performance
USD|Thousands
Reported figures and Equlion model projections for the next 5 years.
ROE
-14.8 pt
Company
Sector average
ROA
-9.6 pt
Company
Gross Margin
-11.3 pt
Company
Sector average
Net Margin
-8.2 pt
Company
Total Assets
-7%
Company
Sector average (own scale)
Net Income
-1,156.1%
Company
Valuation
+135.2%
Company
Stock Price
+138.5%
Company
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Pharma-Bio Serv, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.